Standard compounded tirzepatide injections prescribed through NexLife are $139 a month on the 12-month plan or $169 month to month at every weekly dose from 2.5 mg to 15 mg. Compounded tirzepatide is not FDA-approved.
Standard compounded tirzepatide injections prescribed through NexLife are $139 a month on the 12-month plan or $169 month to month at every weekly dose from 2.5 mg to 15 mg. Compounded tirzepatide is not FDA-approved.